Kamila Blum (Gromek)

Employment

• GlaxoSmithKline Research & Development Limited Toxicologist
  2018 - Present
• Novartis Toxicologist
  2015 - 2018

Education

• University of Geneva Master of Advanced Studies (MAS) in Toxicology
  2018 - 2020
• Medical University of Lublin PharmD
  2006 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Commentary - In silico acute oral toxicity models are fit for inclusion in GHS and DG Model regulations classification criteria
  Regulatory Toxicology and Pharmacology 2026 DOI: 10.1016/j.yrtph.2026.106236
  +Save
• Establishment of a threshold of toxicological concern for pharmaceutical intermediates based on historical repeat-dose data and its application in setting health based exposure limits
  Regulatory Toxicology and Pharmacology 2025 DOI: 10.1016/j.yrtph.2024.105764
  +Save
• Application of a unified probabilistic framework to the dose-response assessment of selected nitrosamines and derivation of health-based exposure limits (HBELs)
  Toxicology Letters 2024 DOI: 10.1016/j.toxlet.2024.07.921
  +Save
• Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics
  Toxicology Letters 2024 DOI: 10.1016/j.toxlet.2024.07.875
  +Save
• Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach
  Regulatory Toxicology and Pharmacology 2024 DOI: 10.1016/j.yrtph.2024.105649
  +Save
• The Application of Skin Sensitization In Silico Models for the Assessment of Pharmaceuticals and Their Related Compounds
  SOT 2024
  +Save
• Use of the benchmark‐dose (BMD) approach to derive occupational exposure limits (OELs) for genotoxic carcinogens: N‐nitrosamines
  Journal of Applied Toxicology 2023 DOI: 10.1002/jat.4455
  +Save
• Controlling cleaning agent residues in pharmaceutical manufacturing: A harmonized scientific strategy
  Regulatory Toxicology and Pharmacology 2023 DOI: 10.1016/j.yrtph.2023.105430
  +Save
• Toxicological evaluation of 2-(Methylsulfonyl)ethylamine (2-AEMS): genotoxicity, acute and 4-week oral toxicity studies in rats
  Toxicology Letters 2023 DOI: 10.1016/s0378-4274(23)00495-2
  +Save
• A Parenteral Permissible Daily Exposure for Inactivated Therapeutic Proteins: An Approach Based on Literature Review
  Bioprocess International 2023
  +Save